Triggering ovulation with leuprolide acetate (LA) instead of human chorionic gonadotropin (hCG) after the use of ganirelix for in vitro fertilization-embryo transfer (IVF-ET) does not compromise cycle outcome and may prevent ovarian hyperstimulation syndrome.

✍ Scribed by N.J Bracero; M.W Jurema; M.N Posada; J.G Whelan; J.E Garcia; N.P Vlahos

• Book ID: 119417585
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 26 KB
• Volume: 76
• Category: Article
• ISSN: 1556-5653
• DOI: 10.1016/s0015-0282(01)02277-4